Health Condition 1: L700- Acne vulgaris Health Condition 2: null- Busur Labaniyya (Acne Vulgaris)
Conditions
Interventions
Intervention1: Group (A) Unani Drugs: Tila-i Muhasa (Local): Patients will be advised to apply Tila-i Muhasa (in the form of paste) locally. 5-10 gm according to affected area, once daily for 42 days.
Sponsors
Central Research Institute of Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: i)Patients of any sex in the age group between 14 and 40 years ii) Clinically stable patients iii) Patients having the following symptoms of Busur Labaniyya: 1. Comedones 2. Papules 3. Pustules 4. Nodules 5. Itching 6. Erythema
Exclusion criteria
Exclusion criteria: 1. Patients aged 40 years 2. Pregnant or Lactating Women 3. Mentally retarded person 4. Patients on corticosteroid or anticonvulsant therapy or taking oral contraceptives 5. Patients suffering from other concomitant diseases like acne rosacea, acne fulminance, acne necrotica, psoriasis, eczema, etc. 6. Significant Pulmonary/Cardiovascular/Hepato-renal dysfunction 7. Patient not willing to attend treatment schedule regularly
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The response to treatment will be assessed using the following parameters: 1. Global Acne Grading System (GAGS) 2. Photographic Standards for Acne Grading (PSAG) 3. Photographic Standards for Acne Grading (PSAG)Timepoint: at baseline 2wk 4wk and 6wk | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the improvement in quality of life in patients with Acne Vulgaris assessed by PGA on VAS and IGATimepoint: at baseline 2wk 4wk and 6wk | — |
Countries
India
Contacts
Public ContactDr Mohammad Nawab
Central Research Institute of Unani Medicine, Hyderabad
Outcome results
None listed